<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report two patients who had symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> after aneurysmal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> and who were treated successfully with intra-aortic balloon pump counterpulsation therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Both patients developed <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> and <z:hpo ids='HP_0100598'>pulmonary edema</z:hpo> while receiving postoperative hypertensive, hypervolemic, hemodilutional (Triple-H) therapy for symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Both cases of <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> were refractory to maximum pressor and inotropic infusions </plain></SENT>
<SENT sid="3" pm="."><plain>Intra-aortic balloon pump counterpulsation was used to optimize cardiac performance to allow continuation of Triple-H therapy and to maintain adequate cerebral perfusion in an attempt to decrease the risk of cerebral ischemic complications </plain></SENT>
<SENT sid="4" pm="."><plain>Both patients have had good long-term outcomes </plain></SENT>
<SENT sid="5" pm="."><plain>These two cases illustrate the potential usefulness of the intra-aortic balloon pump as an adjunct to Triple-H therapy in patients with symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>To our knowledge, this report documents the first clinical application of this adjunctive therapy for vasospasm after aneurysmal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
</text></document>